Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The purpose of this study is to evaluate the efficacy and examine the safety of two doses of EB-1020 QD XR capsule administered once daily orally in adult ADHD patients.
Epistemonikos ID: 9188ce991909d00f330955072cbdcd1dfc37f27b
First added on: Apr 17, 2025